Ventricular Tachycardia, Catecholaminergic Polymorphic, 4; Cpvt4
Genes related to Ventricular Tachycardia, Catecholaminergic Polymorphic, 4; Cpvt4
- CALM1
Clinical Features
Top most frequent phenotypes and symptoms related to Ventricular Tachycardia, Catecholaminergic Polymorphic, 4; Cpvt4
- Arrhythmia
- Vertigo
- Tachycardia
- Syncope
- Bradycardia
- Cardiac arrest
- Ventricular tachycardia
- Ventricular arrhythmia
- Ventricular fibrillation
- Loss of consciousness
And another 2 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Ventricular Tachycardia, Catecholaminergic Polymorphic, 4; Cpvt4 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Comprehensive Cardiac Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RIT1, RYR2, SCN1B, SCN2B, SCN4B, SCN5A, SGCD, SLC22A5, BRAF, SNTA1, SOS1, TAZ, TCAP, TGFB3, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TTN , (...)
View the complete list with 86 more genes
Specificity
1 %
Genes
100 % |
Long QT Syndrome Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
RYR2, SCN4B, SCN5A, SNTA1, TRDN, CACNA1C, CALM1, CALM2, CASQ2, CAV3, AKAP9, ANK2, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1
Specificity
6 %
Genes
100 % |
Catecholaminergic Polymorphic Ventricular Tachycardia.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RYR2, TRDN, CALM1, CASQ2, ANK2, KCNJ2
Specificity
17 %
Genes
100 % |
Comprehensive Arrhythmias Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RYR2, SCN1B, SCN4B, SCN5A, SNTA1, TRDN, CACNA1C, CACNB2, CALM1, CASQ2, CAV3, HCN4, TRPM4, SCN3B, GPD1L, AKAP9, ANK2, KCNE1, KCNE2, KCNE3 , (...)
View the complete list with 3 more genes
Specificity
5 %
Genes
100 % |
Long QT Syndrome and Short QT Syndrome.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SCN4B, SCN5A, SNTA1, CACNA1C, CALM1, CAV3, AKAP9, ANK2, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1
Specificity
8 %
Genes
100 % |
Long QT Syndrome Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SCN4B, SCN5A, SNTA1, CACNA1C, CALM1, CAV3, AKAP9, ANK2, KCNE1, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ1
Specificity
8 %
Genes
100 % |
Cardiac Channelopathy Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RYR2, SCN1B, SCN2B, SCN4B, SCN5A, SNTA1, TRDN, CACNA1C, CACNA2D1, CACNB2, CALM1, CASQ2, CAV3, SLMAP, HCN4, RANGRF, TRPM4, SCN3B, GPD1L, AKAP9 , (...)
View the complete list with 12 more genes
Specificity
4 %
Genes
100 % |
Catecholminergic Polymorphic Ventricular Tachycardia (CPVT) Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RYR2, TRDN, CALM1, CASQ2, ANK2, KCNJ2
Specificity
17 %
Genes
100 % |
You can get up to 85 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like USHER SYNDROME, TYPE IIIA; USH3A IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12 HYPERPIGMENTATION WITH OR WITHOUT HYPOPIGMENTATION, FAMILIAL PROGRESSIVE; FPHH HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE; OCLSBG GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO